Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
Public ClinicalTrials.gov record NCT03911076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-Blind, Placebo-controlled Phase II Trial With Safety Run-In of Intramuscular pNGVL4a-Sig/E7(Detox)/HSP70 and TA-CIN for the Treatment of Patients With HPV16+ Atypical Squamous Cells of Undetermined Significance (ASC-US) or Cannot Exclude High Grade SIL (ASC-H) Cytology or Low-grade Squamous Intraepithelial Lesion (LSIL)
Study identification
- NCT ID
- NCT03911076
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- PapiVax Biotech, Inc.
- Other
- Enrollment
- 16 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 25 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2019
- Primary completion
- Jun 7, 2022
- Completion
- Jun 7, 2022
- Last update posted
- Jun 16, 2024
2019 – 2022
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Health Awareness, Inc. | Port Saint Lucie | Florida | 33458 | — |
| University Hospital, Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | — |
| Obstetrics & Gynecology Associates, Inc. | Fairfield | Ohio | 45014 | — |
| Austin Area Obstetrics, Gynecology, and Fertility | Austin | Texas | 78758 | — |
| Corpus Christi Women's Clinic (Elligo Health Research, Inc.) | Corpus Christi | Texas | 78412 | — |
| MacArthur Medical Center | Irving | Texas | 75062 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03911076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03911076 live on ClinicalTrials.gov.